Using an 8% capsaicin patch for treating chronic pain in children
Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years
This study is testing if an 8% capsaicin patch can help children and teenagers with chronic pain feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 160 (estimated) |
| Ages | N/A to 17 Years |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 20 sites (Angers, France and 19 other locations) |
| Trial ID | NCT05299294 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on children and teenagers under 18 years old who experience chronic localized neuropathic pain and are indicated for treatment with an 8% capsaicin patch. Participants will be monitored for tolerance and efficacy through regular assessments and phone calls from the investigational team. Data will be collected on pain levels and treatment responses at various intervals following the application of the patch. The study aims to validate the use of this treatment in a pediatric population.
Who should consider this trial
Good fit: Ideal candidates are children and teenagers under 18 years old with chronic localized neuropathic pain who have been validated for capsaicin 8% patch treatment.
Not a fit: Patients who have previously been treated with the capsaicin 8% patch in the same body area or those unwilling to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide an effective pain management option for children suffering from chronic neuropathic pain.
How similar studies have performed: While the use of capsaicin patches has been studied in adults, this specific application in a pediatric population is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * chronic localized neuropathic pain * capsaicin 8% patch treatment indication validated in a pediatric chronic pain center * agreement for participation by child and parents Exclusion Criteria: * already treated with capsaicin 8% patch in the same body area * already treated in the same study in an other investigation center * non willing to participate or parents not willing participation to the study
Where this trial is running
Angers, France and 19 other locations
- CHU Angers — Angers, France, France (Not_yet_recruiting)
- CHU Bordeaux — Bordeaux, France, France (Recruiting)
- CHR Bourg en Bresse — Bourg-en-Bresse, France, France (Not_yet_recruiting)
- CHU de Brest — Brest, France, France (Recruiting)
- CHU Caen — Caen, France, France (Recruiting)
- CHU Grenoble — Grenoble, France, France (Not_yet_recruiting)
- CHU Lille — Lille, France, France (Recruiting)
- CHU Limoges — Limoges, France, France (Not_yet_recruiting)
- CHU Marseille — Marseille, France, France (Recruiting)
- CHU Montpellier — Montpellier, France, France (Recruiting)
- CHU Nancy — Nancy, France, France (Not_yet_recruiting)
- CHU Nantes — Nantes, France, France (Recruiting)
- CHU Robert Debré — Paris, France, France (Not_yet_recruiting)
- CHU Trousseau — Paris, France, France (Not_yet_recruiting)
- CHU Rouen — Rouen, France, France (Recruiting)
- CHRU Strasbourg — Strasbourg, France, France (Recruiting)
- CHU Toulouse — Toulouse, France, France (Recruiting)
- Institut Gustave Roussy — Villejuif, France, France (Recruiting)
- CHU d'Amiens — Amiens, France (Not_yet_recruiting)
- CHU Lyon — Lyon, France (Recruiting)
Study contacts
- Principal investigator: Philippe J Le Moine, MD — CHRU of Brest
- Study coordinator: Philippe J Le Moine, MD
- Email: philippe.lemoine@chu-brest.fr
- Phone: +33298223956
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.